ATLANTIC CITY, NJ - Opening statements took place Monday in a civil trial against drug manufacturer Merck & Company (NYSE: MRK) involving the widely-prescribed drug Fosamax.
0 Comments Click here to read/write comments
Topics: Pharmaceutical, Mass Torts, In re: Fosamax
ATLANTIC CITY, NJ - Opening statements are scheduled for March 1st in the second lawsuit to go to trial in state court involving the widely-prescribed drug Fosamax.
0 Comments Click here to read/write comments
Topics: Pharmaceutical, In re: Fosamax
Rosenberg v. Merck -- A New Jersey jury this morning found that a Fosamax user did not suffer from osteonecrosis of the jaw (ONJ), and therefore she failed to show that Fosamax caused the harm.
0 Comments Click here to read/write comments
Topics: Toxic Torts, Products Liability, Pharmaceutical, In re: Fosamax
Closing arguments in Rosenberg v. Merck were heard today in Atlantic City, New Jersey. Defense attorney Christy Jones, of Butler Snow, went first.
0 Comments Click here to read/write comments
Topics: Products Liability, Pharmaceutical, In re: Fosamax
Opening statements were heard today in the first state court Fosamax products liability trial, Rosenberg v. Merck.
0 Comments Click here to read/write comments
Topics: Toxic Torts, Products Liability, Pharmaceutical, In re: Fosamax
